Stay updated on Pfizer Press Releases

Sign up to get notified when there's something new on the Pfizer Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Pfizer Press Releases page

  1. Check
    today
    Change Detected
    Summary
    New archive entries for February 2026 and December 16, 2025 were added, including 'Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance' and 'Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial'. The archive also removes the December 16 webcast invitation and the 11.21.2025 entry announcing that PADCEV plus Keytruda received FDA approval for certain bladder cancer patients.
    Difference
    8%
    Check dated 2026-02-04T10:25:40.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a new press release entry: 'Pfizer’s BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer' (01.10.2026) under Medicines. Removed the item 'Pfizer Completes Acquisition of Metsera' (11.13.2025) from Corporate.
    Difference
    2%
    Check dated 2026-01-14T03:27:11.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    January 2026 entries (01.05.2026) were added to the Press Release Archive, and the 11.12.2025 entry was removed. The archive now reflects the latest releases for the start of 2026.
    Difference
    2%
    Check dated 2026-01-07T01:44:27.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Added three December 2025 press releases to the Pfizer Press Release Archive and removed three November 2025 entries.
    Difference
    8%
    Check dated 2025-12-23T21:16:30.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    December 2025 press releases were added to the archive (Pfizer Declares First-Quarter 2026 Dividend; TUKYSA maintenance therapy update; Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma), and October 2025 items were removed from the archive.
    Difference
    7%
    Check dated 2025-12-16T20:23:29.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Summary
    Added a new press release entry under Prescription Medicines for HYMPAVZI® (marstacimab) dated 12.06.2025. Removed the 'Research and Pipeline' category and the press release 'XTANDI® Plus Leuprolide Reduced Risk of Death by 40% vs Leuprolide Alone in Men with a Type of Advanced Prostate Cancer' dated 10.19.2025.
    Difference
    1%
    Check dated 2025-12-09T18:53:23.000Z thumbnail image

Stay in the know with updates to Pfizer Press Releases

Enter your email address, and we'll notify you when there's something new on the Pfizer Press Releases page.